Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension.
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis; D005333:Fetus / Q000187:drug effects / Q000502:physiology; D006128:Growth; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007231:Infant, Newborn; D008750:Methyldopa / Q000627:therapeutic use; D010121:Oxytocin; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011296:Prenatal Diagnosis; D014463:Ultrasonography
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D010121:Oxytocin; D008750:Methyldopa